Advertisement
Screener

Redmile Group, LLC Historic Quarter Change: USA Other Stocks, Sold Out

Redmile Group, LLC historic quarter change: USA Other Stocks, Sold out

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 24 quarters from 2013-03-31 to 2026-06-30, Redmile Group, LLC opened 142 positions, added to 146, reduced 174 and sold out of 160.

  • Q3 2025: Stock VERVE THERAPEUTICS INC; Country of operation United States; Class COM; Shares before 740,261.
  • Q3 2025: Stock IGM BIOSCIENCES INC; Country of operation United States; Class COM; Shares before 2,952,131.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1425738), 24 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-15); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-16); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-17); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-18); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-15); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-08-19); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14); Q2 2013 (2013-03-31 to 2013-06-30, filed 2013-08-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2007-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2025VERVE THERAPEUTICS INC
CUSIP 92539P101
United StatesCOM740,2610-740,261$8,313,131$0-$8,313,1312025-11-14
Q3 2025IGM BIOSCIENCES INC
CUSIP 449585108
United StatesCOM2,952,1310-2,952,131$3,306,387$0-$3,306,3872025-11-14

Similar Firms

Firm NameCountry13F ValueHoldings
OAK RIDGE INVESTMENTS LLCUnited States$1.512B181
Howard Capital Management Group, LLCUnited States$1.507B144
F/m Investments LLCUnited States$1.506B333
FAIRHOLME CAPITAL MANAGEMENT LLCUnited States$1.514B10
SG Capital Management LLCUnited States$1.506B88
Kepler Cheuvreux (Suisse) SASwitzerland$1.505B222
PDS Planning, IncUnited States$1.516B561
ARES MANAGEMENT LLCUnited States$1.517B37
Caligan Partners LPUnited States$1.503B28
SVB WEALTH LLCUnited States$1.518B1,500